UBS analyst Ashwani Verma lowered the price target on Legend Biotech Corp. (NASDAQ: LEGN) to $54.00 (from $60.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE